ATE254123T1 - Benzazolderivate und ihre verwendung als jnk modulatoren - Google Patents

Benzazolderivate und ihre verwendung als jnk modulatoren

Info

Publication number: ATE254123T1
Authority: AT; Austria
Prior art keywords: benzazole derivatives; jnk modulators; jnk; modulators; benzazole
Prior art date: 1999-12-24

Application number

AT00991229T

Other languages

English (en)

Inventor

Serge Halazy

Dennis Church

Montserrat Camps

Pascale Gaillard

Jean-Pierre Gotteland

Original Assignee

Applied Research Systems

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-12-24

Filing date

2000-12-20

Publication date

2003-11-15

2000-12-20 Application filed by Applied Research Systems filed Critical Applied Research Systems

2003-11-15 Application granted granted Critical

2003-11-15 Publication of ATE254123T1 publication Critical patent/ATE254123T1/de

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Immunology (AREA)
Cardiology (AREA)
Pulmonology (AREA)
Heart & Thoracic Surgery (AREA)
Pain & Pain Management (AREA)
Physical Education & Sports Medicine (AREA)
Hospice & Palliative Care (AREA)
Psychology (AREA)
Rheumatology (AREA)
Oncology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Psychiatry (AREA)
Orthopedic Medicine & Surgery (AREA)
Transplantation (AREA)
Communicable Diseases (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

AT00991229T 1999-12-24 2000-12-20 Benzazolderivate und ihre verwendung als jnk modulatoren ATE254123T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP99811207A EP1110957A1 (de)	1999-12-24	1999-12-24	Benzazolderivate und ihre Verwendung als JNK Modulatoren
PCT/EP2000/013006 WO2001047920A1 (en)	1999-12-24	2000-12-20	Benzazole derivatives and their use as jnk modulators

Publications (1)

Publication Number	Publication Date
ATE254123T1 true ATE254123T1 (de)	2003-11-15

Family

ID=8243214

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT00991229T ATE254123T1 (de)	1999-12-24	2000-12-20	Benzazolderivate und ihre verwendung als jnk modulatoren

Country Status (33)

Country	Link
US (2)	US7259162B2 (de)
EP (2)	EP1110957A1 (de)
JP (1)	JP4782344B2 (de)
KR (2)	KR100736012B1 (de)
CN (1)	CN1252067C (de)
AR (1)	AR029215A1 (de)
AT (1)	ATE254123T1 (de)
AU (1)	AU780241B2 (de)
BG (1)	BG65986B1 (de)
BR (1)	BR0016911A (de)
CA (1)	CA2394809C (de)
CZ (1)	CZ300984B6 (de)
DE (1)	DE60006580T2 (de)
DK (1)	DK1240164T3 (de)
EA (1)	EA007152B1 (de)
EE (1)	EE05456B1 (de)
ES (1)	ES2206351T3 (de)
HK (1)	HK1055730A1 (de)
HR (1)	HRP20020496B1 (de)
HU (1)	HU229625B1 (de)
IL (2)	IL150346A0 (de)
MX (1)	MXPA02006242A (de)
NO (1)	NO323146B1 (de)
NZ (1)	NZ519423A (de)
PL (1)	PL356634A1 (de)
PT (1)	PT1240164E (de)
RS (1)	RS51008B (de)
SI (1)	SI1240164T1 (de)
SK (1)	SK287546B6 (de)
TR (2)	TR200302320T4 (de)
UA (1)	UA73151C2 (de)
WO (1)	WO2001047920A1 (de)
ZA (1)	ZA200204427B (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1380576B1 (de)	2001-04-16	2009-11-25	Eisai R&D Management Co., Ltd.	1h-indazolverbindungen die jnk hemmen
AU2002331253B2 (en)	2001-07-23	2008-04-03	Laboratoires Serono Sa	Arylsulfonamide derivatives as C-JUN-N-terminal kinases (JNK'S) inhibitors
ES2268127T3 (es) *	2001-12-07	2007-03-16	Applied Research Systems Ars Holding N.V.	Derivados de benzazol para el tratamiento de esclerodermia.
DK1501828T3 (da) *	2002-04-25	2008-03-10	Serono Lab	Piperazinbenzothiazoler som midler til behandling af cerebrale iskæmiske lidelser eller CNS-lidelser
CN1656079A (zh)	2002-05-31	2005-08-17	卫材株式会社	吡唑化合物和含有该化合物的药物组合物
US7465736B2 (en)	2002-06-14	2008-12-16	Laboratoires Serono S.A.	Azole methylidene cyanide derivatives and their use as protein kinase modulators
CA2501144C (en)	2002-10-23	2015-10-06	University Of Utah Research Foundation	Amplicon melting analysis with saturation dyes
EP1633363B1 (de) *	2003-05-08	2012-11-07	Merck Serono SA	Pyridinyl acetonitrile
WO2005025567A1 (en) *	2003-09-12	2005-03-24	Applied Research Systems Ars Holding N.V.	Benzothiazole derivatives for the treatment of diabetes
US20070185104A1 (en) *	2003-09-12	2007-08-09	Applied Research Systems Ars Holding N.V.	Benzoxazole acetonitriles
AU2004272306A1 (en) *	2003-09-12	2005-03-24	Merck Serono Sa	Benzimidazole acetonitriles
KR20060134198A (ko) *	2004-04-08	2006-12-27	어플라이드 리서치 시스템스 에이알에스 홀딩 엔.브이.	Ｊｎｋ 저해제 및 시클로스포린을 포함하는 조성물
US7387887B2 (en) *	2004-04-20	2008-06-17	University Of Utah Research Foundation	Nucleic acid melting analysis with saturation dyes
US9657347B2 (en)	2004-04-20	2017-05-23	University of Utah Research Foundation and BioFire Defense, LLC	Nucleic acid melting analysis with saturation dyes
US20060094753A1 (en)	2004-10-29	2006-05-04	Alcon, Inc.	Use of inhibitors of Jun N-terminal kinases for the treatment of glaucomatous retinopathy and ocular diseases
US7803824B2 (en)	2004-10-29	2010-09-28	Alcon, Inc.	Use of inhibitors of Jun N-terminal kinases to treat glaucoma
PL1812072T3 (pl) *	2004-11-17	2009-04-30	Ares Trading Sa	Benzotiazolowe formulacje oraz ich zastosowanie
US7838522B2 (en)	2004-11-17	2010-11-23	Ares Trading S.A.	Benzothiazole formulations and use thereof
ZA200704921B (en)	2004-12-21	2008-09-25	Serono Lab	Sulfonyl amino cyclic derivatives and use thereof
KR20070105326A (ko)	2005-01-31	2007-10-30	라보라뚜와르 세로노 에스. 에이.	Ｎ-하이드록시아미드 유도체 및 그것의 용도
US20060223807A1 (en)	2005-03-29	2006-10-05	University Of Massachusetts Medical School, A Massachusetts Corporation	Therapeutic methods for type I diabetes
BRPI0613042A2 (pt)	2005-07-15	2010-12-14	Serono Lab	inibidores de jnk para o tratamento de endometriose
KR20080044836A (ko)	2005-07-15	2008-05-21	라보라뚜와르 세로노 에스. 에이.	자궁내막증 치료용 ｊｎｋ 억제제
EA013816B1 (ru)	2005-09-01	2010-08-30	Арес Трейдинг С.А.	Лечение неврита зрительного нерва
ZA200804717B (en)	2005-12-29	2010-02-24	Anthrogenesis Corp	Improved composition for collecting and preserving a placental stem cells and methods of using the composition
EP2026802A2 (de) *	2006-06-02	2009-02-25	Laboratoires Serono SA	Jnk-hemmer zur behandlung von hautkrankheiten
US20090194268A1 (en) *	2006-08-28	2009-08-06	Dantherm Air Handling A/S	Method for manufacturing a heat exchanger
EP2129775A1 (de)	2007-02-12	2009-12-09	Anthrogenesis Corporation	Hepatocyten und chondrocyten aus adhärenten plazentastammzellen sowie cd34+, cd45- plazentastammzellenangereicherte zellpopulationen
CN102177157A (zh) *	2008-08-12	2011-09-07	西特里斯药业公司	作为沉默调节蛋白调节剂的苯并*唑类、苯并噻唑类和相关的类似物
US8129396B2 (en) *	2008-09-29	2012-03-06	Telik, Inc.	2-[1H-benzimidazol-2(3H)-ylidene]-2-(pyrimidin-2-yl)acetamides and 2-[benzothiazol-2(3H)-ylidene]-2-(pyrimidin-2-yl)acetamides as kinase inhibitors
AU2011352036A1 (en)	2010-12-31	2013-07-18	Anthrogenesis Corporation	Enhancement of placental stem cell potency using modulatory RNA molecules
CN102199147A (zh) *	2011-03-19	2011-09-28	陕西合成药业有限公司	用于治疗的硝基咪唑衍生物
AU2012262273B2 (en)	2011-06-01	2017-09-14	Celularity Inc.	Treatment of pain using placental stem cells
WO2014114186A1 (zh) *	2013-01-24	2014-07-31	山东亨利医药科技有限责任公司	Jnk抑制剂
EP3082422A4 (de) *	2013-12-20	2017-07-05	Biomed Valley Discoveries, Inc.	Krebsbehandlungen unter verwendung von kombinationen aus typ-1-mek- und -erk-hemmern
KR101520378B1 (ko) *	2014-10-02	2015-05-26	(주)에프테크	습식 가스 스크러버의 배기유도장치
BR112017007178A2 (pt)	2014-10-08	2017-12-19	Ass Francaise Contre Les Myopathies	compostos de aminopiridina úteis como inibidores de prenilação de proteína

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2918369A (en) *	1956-06-15	1959-12-22	Gen Aniline & Film Corp	Non-ionic benzimidazole cyanine dyes containing in alpha-position a cyano group on the methenyl chain
GB864131A (en) *	1957-07-17	1961-03-29	Ciba Ltd	Benzimidazolyl-acetic acid derivatives
DE1963542A1 (de)	1969-12-18	1971-06-24	Siemens Ag	Koppelfeldanordnung fuer Fernmelde-,insbesondere Fernsprechanlagen
JPS51123223A (en) *	1975-04-21	1976-10-27	Fuji Photo Film Co Ltd	Process for producing condensation products
CH593954A5 (de) *	1975-07-21	1977-12-30	Ciba Geigy Ag
US4933341A (en) *	1988-10-08	1990-06-12	Bayer Aktiengesellschaft	Substituted 1,3,5-triazinetriones, for use against parasitic protozoa
EP0364765A3 (de) *	1988-10-08	1991-07-17	Bayer Ag	Substituierte 1,3,5-Triazintrione, Verfahren zu ihrer Herstellung und ihre Verwendung gegen parasitäre Protozoen
US5523312A (en) *	1994-09-27	1996-06-04	Sterling Winthrop Inc.	Antipicornaviral agents
US6043083A (en)	1997-04-28	2000-03-28	Davis; Roger J.	Inhibitors of the JNK signal transduction pathway and methods of use
JP4153574B2 (ja) *	1997-09-10	2008-09-24	トーアエイヨー株式会社	新規なピペリジン誘導体、その製造法およびそれを含有する循環器官用剤
GB9721437D0 (en) *	1997-10-10	1997-12-10	Glaxo Group Ltd	Heteroaromatic compounds and their use in medicine

1999
- 1999-12-24 EP EP99811207A patent/EP1110957A1/de not_active Withdrawn
2000
- 2000-12-20 KR KR1020027007971A patent/KR100736012B1/ko not_active IP Right Cessation
- 2000-12-20 TR TR2003/02320T patent/TR200302320T4/xx unknown
- 2000-12-20 KR KR1020077008852A patent/KR20070047853A/ko active Search and Examination
- 2000-12-20 PT PT00991229T patent/PT1240164E/pt unknown
- 2000-12-20 CN CNB008187045A patent/CN1252067C/zh not_active Expired - Lifetime
- 2000-12-20 DK DK00991229T patent/DK1240164T3/da active
- 2000-12-20 AT AT00991229T patent/ATE254123T1/de active
- 2000-12-20 AU AU31616/01A patent/AU780241B2/en not_active Expired
- 2000-12-20 UA UA2002065195A patent/UA73151C2/uk unknown
- 2000-12-20 BR BR0016911-0A patent/BR0016911A/pt not_active Application Discontinuation
- 2000-12-20 EA EA200200708A patent/EA007152B1/ru not_active IP Right Cessation
- 2000-12-20 CA CA2394809A patent/CA2394809C/en not_active Expired - Lifetime
- 2000-12-20 IL IL15034600A patent/IL150346A0/xx unknown
- 2000-12-20 EE EEP200200318A patent/EE05456B1/xx not_active IP Right Cessation
- 2000-12-20 SK SK898-2002A patent/SK287546B6/sk not_active IP Right Cessation
- 2000-12-20 ES ES00991229T patent/ES2206351T3/es not_active Expired - Lifetime
- 2000-12-20 CZ CZ20022169A patent/CZ300984B6/cs not_active IP Right Cessation
- 2000-12-20 HU HU0204557A patent/HU229625B1/hu not_active IP Right Cessation
- 2000-12-20 EP EP00991229A patent/EP1240164B1/de not_active Expired - Lifetime
- 2000-12-20 TR TR2002/01509T patent/TR200201509T2/xx unknown
- 2000-12-20 RS YUP-492/02A patent/RS51008B/sr unknown
- 2000-12-20 MX MXPA02006242A patent/MXPA02006242A/es active IP Right Grant
- 2000-12-20 WO PCT/EP2000/013006 patent/WO2001047920A1/en active IP Right Grant
- 2000-12-20 SI SI200030254T patent/SI1240164T1/xx unknown
- 2000-12-20 NZ NZ519423A patent/NZ519423A/en not_active IP Right Cessation
- 2000-12-20 DE DE60006580T patent/DE60006580T2/de not_active Expired - Lifetime
- 2000-12-20 PL PL00356634A patent/PL356634A1/xx unknown
- 2000-12-20 US US10/168,718 patent/US7259162B2/en not_active Expired - Lifetime
- 2000-12-20 JP JP2001549390A patent/JP4782344B2/ja not_active Expired - Lifetime
- 2000-12-22 AR ARP000106912A patent/AR029215A1/es active IP Right Grant
2002
- 2002-06-03 ZA ZA200204427A patent/ZA200204427B/en unknown
- 2002-06-06 HR HR20020496A patent/HRP20020496B1/xx not_active IP Right Cessation
- 2002-06-18 BG BG106830A patent/BG65986B1/bg unknown
- 2002-06-20 IL IL150346A patent/IL150346A/en not_active IP Right Cessation
- 2002-06-21 NO NO20022997A patent/NO323146B1/no not_active IP Right Cessation
2003
- 2003-11-05 HK HK03107978A patent/HK1055730A1/xx not_active IP Right Cessation
2007
- 2007-07-18 US US11/779,585 patent/US7470686B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
DE60006580D1 (de)	2003-12-18
KR100736012B1 (ko)	2007-07-06
US7470686B2 (en)	2008-12-30
HU229625B1 (hu)	2014-03-28
SK287546B6 (sk)	2011-01-04
BR0016911A (pt)	2002-10-22
EE05456B1 (et)	2011-08-15
CN1252067C (zh)	2006-04-19
CN1433414A (zh)	2003-07-30
TR200201509T2 (tr)	2002-09-23
AU780241B2 (en)	2005-03-10
IL150346A0 (en)	2002-12-01
CZ300984B6 (cs)	2009-09-30
MXPA02006242A (es)	2003-01-28
HK1055730A1 (en)	2004-01-21
TR200302320T4 (tr)	2004-01-21
HRP20020496B1 (en)	2009-03-31
DE60006580T2 (de)	2004-09-16
PT1240164E (pt)	2004-02-27
RS51008B (sr)	2010-10-31
EP1110957A1 (de)	2001-06-27
JP4782344B2 (ja)	2011-09-28
AR029215A1 (es)	2003-06-18
NZ519423A (en)	2004-04-30
US20030162794A1 (en)	2003-08-28
EP1240164A1 (de)	2002-09-18
EP1240164B1 (de)	2003-11-12
WO2001047920A1 (en)	2001-07-05
CA2394809C (en)	2011-03-15
BG65986B1 (bg)	2010-08-31
ZA200204427B (en)	2004-02-03
EA007152B1 (ru)	2006-08-25
KR20070047853A (ko)	2007-05-07
CZ20022169A3 (cs)	2002-09-11
HRP20020496A2 (en)	2006-03-31
UA73151C2 (en)	2005-06-15
PL356634A1 (en)	2004-06-28
EA200200708A1 (ru)	2003-02-27
JP2003519142A (ja)	2003-06-17
SK8982002A3 (en)	2002-10-08
HUP0204557A2 (en)	2003-05-28
NO20022997L (no)	2002-06-21
HUP0204557A3 (en)	2009-03-30
CA2394809A1 (en)	2001-07-05
US20070259892A1 (en)	2007-11-08
EE200200318A (et)	2003-10-15
NO20022997D0 (no)	2002-06-21
US7259162B2 (en)	2007-08-21
IL150346A (en)	2010-12-30
AU3161601A (en)	2001-07-09
BG106830A (bg)	2003-02-28
KR20020072282A (ko)	2002-09-14
NO323146B1 (no)	2007-01-08
DK1240164T3 (da)	2004-03-01
ES2206351T3 (es)	2004-05-16
YU49202A (sh)	2006-01-16
SI1240164T1 (en)	2004-04-30

Publication	Publication Date	Title
DE60006580D1 (de)	2003-12-18	Benzazolderivate und ihre verwendung als jnk modulatoren
DE60036803D1 (de)	2007-11-29	Arylmethyl-carbonylamino-thiazolderivate und ihre verwendung als antitumormittel
ATE252091T1 (de)	2003-11-15	Biaryl-oxa(thia)zolderivate und ihre verwendung als ppars modulatoren
DE60031513D1 (de)	2006-12-07	Phenyl- und pyridinyl-derivate verwendbar als neurokinin-1-antagonisten
DE60039539D1 (de)	2008-08-28	4-aminopiperidin-derivate und ihre verwendung als arzneimittel
ATE302193T1 (de)	2005-09-15	Benzoheterozyklen und ihre verwendung als mek inhibitoren
DE50008597D1 (de)	2004-12-16	Thiazolylharnstoff-derivate und ihre verwendung als antivirale mittel
DE59710422D1 (de)	2003-08-14	Acylmercapto-triazolyl-derivate und ihre verwendung als mikrobizide
DE59710580D1 (de)	2003-09-18	Thiocyano-triazolyl-derivate und ihre verwendung als mikrobizide
ATE398108T1 (de)	2008-07-15	Chinolinderivate und deren verwendung als 5-ht6 liganden
DE60139477D1 (de)	2009-09-17	2-cyanopyrrolidin-derivate und ihre verwendung als arzneimittel
DE60041343D1 (de)	2009-02-26	Oxa- und thiazolderivate sowie ihre verwendung gegen diabetes und fettsucht
DE60016326D1 (de)	2005-01-05	Wasser-absorbierende Zusammensetzung und ihre Verwendung
ATE362469T1 (de)	2007-06-15	2,7-disubstituierteindole und ihre verwendung als 5-ht6 modulatoren
DE60322551D1 (de)	2008-09-11	2,4-substituierte indole und deren verwendung als 5-ht6 modulatoren
DE50003275D1 (de)	2003-09-18	Substituierte benzoylisoxazole und ihre verwendung als herbizide
DE69902387D1 (de)	2002-09-05	Oxadiazolinderivate und ihre verwendung als insektizide
DE60009911D1 (de)	2004-05-19	Aminothiazolderivate und ihre verwendung als crf-rezeptor-liganden
DE50008549D1 (de)	2004-12-09	Triazolotriazinone und ihre verwendung
ATE268327T1 (de)	2004-06-15	Benzazol-verbindungen und ihre verwendung
DE60116732D1 (de)	2006-04-06	Isothiazol-derivate und ihre verwendung als schädlingsbekämpfungsmittel
ATE253059T1 (de)	2003-11-15	Substituierte 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2- one und ihre verwendung als lipase-hemmer
ATE229016T1 (de)	2002-12-15	Substituierte heterocyclische benzocycloalkene und ihre verwendung als analgetisch wirksame substanzen
DE69821988D1 (de)	2004-04-01	Substituierte isochinoline derivate und ihre verwendung als anticonvulsiva
ATE368654T1 (de)	2007-08-15	Benzothiazol- und benzoxazol-4,7-dionderivate und ihre verwendung als cdc25-phosphatasen- inhibitoren

Legal Events

Date	Code	Title	Description
2004-08-15	UEP	Publication of translation of european patent specification	Ref document number: 1240164 Country of ref document: EP
2011-04-15	EEFA	Change of the company name

Date

Code

Title

Description

2004-08-15

UEP

Publication of translation of european patent specification

Ref document number: 1240164

Country of ref document: EP

2011-04-15

EEFA

Change of the company name